{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:21:28Z","timestamp":1793658088041,"version":"4.5.1"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["Z01-AI-000988, Z01-AI-000644"],"award-info":[{"award-number":["Z01-AI-000988, Z01-AI-000644"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R00 CA218870, P01 HL142494"],"award-info":[{"award-number":["R00 CA218870, P01 HL142494"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Ex vivo<\/jats:italic>\n                      gene therapy for treatment of Inborn errors of Immunity (IEIs) have demonstrated significant clinical benefit in multiple Phase I\/II clinical trials. Current approaches rely on engineered retroviral vectors to randomly integrate copy(s) of gene-of-interest in autologous hematopoietic stem\/progenitor cells (HSPCs) genome permanently to provide gene function in transduced HSPCs and their progenies. To circumvent concerns related to potential genotoxicities due to the random vector integrations in HSPCs, targeted correction with CRISPR-Cas9-based genome editing offers improved precision for functional correction of multiple IEIs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We compare the two approaches for integration of\n                      <jats:italic>IL2RG<\/jats:italic>\n                      transgene for functional correction of HSPCs from patients with X-linked Severe Combined Immunodeficiency (SCID-X1 or XSCID); delivery\n                      <jats:italic>via<\/jats:italic>\n                      current clinical lentivector (LV)-\n                      <jats:italic>IL2RG<\/jats:italic>\n                      versus targeted insertion (TI) of\n                      <jats:italic>IL2RG via<\/jats:italic>\n                      homology-directed repair (HDR) when using an adeno-associated virus (AAV)-\n                      <jats:italic>IL2RG<\/jats:italic>\n                      donor following double-strand DNA break at the endogenous\n                      <jats:italic>IL2RG<\/jats:italic>\n                      locus.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results and discussion<\/jats:title>\n                    <jats:p>\n                      <jats:italic>In vitro<\/jats:italic>\n                      differentiation of LV- or TI-treated XSCID HSPCs similarly overcome differentiation block into Pre-T-I and Pre-T-II lymphocytes but we observed significantly superior development of NK cells when corrected by TI (40.7% versus 4.1%, p = 0.0099). Transplants into immunodeficient mice demonstrated robust engraftment (8.1% and 23.3% in bone marrow) for LV- and TI-\n                      <jats:italic>IL2RG<\/jats:italic>\n                      HSPCs with efficient T cell development following TI-\n                      <jats:italic>IL2RG<\/jats:italic>\n                      in all four patients\u2019 HSPCs. Extensive specificity analysis of CRISPR-Cas9 editing with rhAmpSeq covering 82 predicted off-target sites found no evidence of indels in edited cells before (\n                      <jats:italic>in vitro<\/jats:italic>\n                      ) or following transplant, in stark contrast to LV\u2019s non-targeted vector integration sites. Together, the improved efficiency and safety of\n                      <jats:italic>IL2RG<\/jats:italic>\n                      correction\n                      <jats:italic>via<\/jats:italic>\n                      CRISPR-Cas9-based TI approach provides a strong rationale for a clinical trial for treatment of XSCID patients.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2022.1067417","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T11:04:50Z","timestamp":1672830290000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["CRISPR-Cas9-AAV versus lentivector transduction for genome modification of X-linked severe combined immunodeficiency hematopoietic stem cells"],"prefix":"10.3389","volume":"13","author":[{"given":"Julie","family":"Brault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uimook","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Kozhushko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Bzhilyanskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Pavel-Dinu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald J.","family":"Meis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Eckhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra S.","family":"Burkett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marita","family":"Bosticardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin P.","family":"Kleinstiver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi D.","family":"Notarangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cicera R.","family":"Lazzarotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengdar Q.","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary A.","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew H.","family":"Porteus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry L.","family":"Malech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suk See","family":"De Ravin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1401177","article-title":"Transplantation outcomes for severe combined immunodeficiency 2000-2009","volume":"371","author":"Pai","year":"2014","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1126\/science.288.5466.669","article-title":"Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease","volume":"288","author":"Cavazzana-Calvo","year":"2000","journal-title":"Science"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1","volume":"118","author":"Hacein-Bey-Abina","year":"2008","journal-title":"J Clin Invest"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1126\/science.1088547","article-title":"LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1404588","article-title":"A modified gamma-retrovirus vector for X-linked severe combined immunodeficiency","volume":"371","author":"Hacein-Bey-Abina","year":"2014","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mt.6300393","article-title":"Self-inactivating gammaretroviral vectors for gene therapy of X-linked severe combined immunodeficiency","volume":"16","author":"Thornhill","year":"2008","journal-title":"Mol Ther"},{"key":"B7","doi-asserted-by":"publisher","first-page":"335ra57","DOI":"10.1126\/scitranslmed.aad8856","article-title":"Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency","volume":"8","author":"De Ravin","year":"2016","journal-title":"Sci Transl Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1815408","article-title":"\u2018Lentiviral gene therapy combined with low-dose busulfan in infants with SCID-X1\u2019","volume":"380","author":"Mamcarz","year":"2019","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1172\/JCI62189","article-title":"Whole transcriptome characterization of aberrant splicing events induced by lentiviral vector integrations","volume":"122","author":"Cesana","year":"2012","journal-title":"J Clin Invest"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nature09328","article-title":"Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia","volume":"467","author":"Cavazzana-Calvo","year":"2010","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.1038\/s41467-022-31344-x","article-title":"Lentivector cryptic splicing mediates increase in CD34+ clones expressing truncated HMGA2 in human X-linked severe combined immunodeficiency","volume":"13","author":"De Ravin","year":"2022","journal-title":"Nat Commun"},{"key":"B12","doi-asserted-by":"publisher","first-page":"5624","DOI":"10.1038\/s41467-019-13620-5","article-title":"Author correction: Gene correction for SCID-X1 in long-term hematopoietic stem cells","volume":"10","author":"Pavel-Dinu","year":"2019","journal-title":"Nat Commun"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan0820","article-title":"Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1","volume":"9","author":"Schiroli","year":"2017","journal-title":"Sci Transl Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3290","article-title":"Chemically modified guide RNAs enhance CRISPR-cas genome editing in human primary cells","volume":"33","author":"Hendel","year":"2015","journal-title":"Nat Biotechnol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021011192","article-title":"CRISPR-targeted MAGT1 insertion restores XMEN patient hematopoietic stem cells and lymphocytes","volume":"2021","author":"Brault","year":"2021","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008503","article-title":"Enhanced homology-directed repair for highly efficient gene editing in hematopoietic stem\/progenitor cells","volume":"137","author":"De Ravin","year":"2021","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41434-021-00251-z","article-title":"Correction of X-CGD patient HSPCs by targeted CYBB cDNA insertion using CRISPR\/Cas9 with 53BP1 inhibition for enhanced homology-directed repair","volume":"28","author":"Sweeney","year":"2021","journal-title":"Gene Ther"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001730","article-title":"Artificial thymic organoids represent a reliable tool to study T-cell differentiation in patients with severe T-cell lymphopenia","volume":"4","author":"Bosticardo","year":"2020","journal-title":"Blood Adv"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.4237","article-title":"Generation of mature T cells from human hematopoietic stem and progenitor cells in artificial thymic organoids","volume":"14","author":"Seet","year":"2017","journal-title":"Nat Methods"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2010.158","article-title":"AML xenograft efficiency is significantly improved in NOD\/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3","volume":"24","author":"Wunderlich","year":"2010","journal-title":"Leukemia"},{"key":"B21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.alit.2017.06.003","article-title":"Flow cytometry-based diagnosis of primary immunodeficiency diseases","volume":"67","author":"Kanegane","year":"2018","journal-title":"Allergol Int"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku936","article-title":"Easy quantitative assessment of genome editing by sequence trace decomposition","volume":"42","author":"Brinkman","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0555-7","article-title":"CHANGE-seq reveals genetic and epigenetic effects on CRISPR-Cas9 genome-wide activity","volume":"38","author":"Lazzarotto","year":"2020","journal-title":"Nat Biotechnol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1472-6750-11-80","article-title":"RNase h-dependent PCR (rhPCR): improved specificity and single nucleotide polymorphism detection using blocked cleavable primers","volume":"11","author":"Dobosy","year":"2011","journal-title":"BMC Biotechnol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2020.04.027","article-title":"Increasing CRISPR efficiency and measuring its specificity in HSPCs using a clinically relevant system","volume":"17","author":"Shapiro","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"key":"B26","doi-asserted-by":"publisher","first-page":"360ra134","DOI":"10.1126\/scitranslmed.aaf9336","article-title":"Selection-free genome editing of the sickle mutation in human adult hematopoietic stem\/progenitor cells","volume":"8","author":"DeWitt","year":"2016","journal-title":"Sci Transl Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/stem.2935","article-title":"Improving gene editing outcomes in human hematopoietic stem and progenitor cells by temporal control of DNA repair","volume":"37","author":"Lomova","year":"2019","journal-title":"Stem Cells"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2019.05.014","article-title":"Editing the sickle cell disease mutation in human hematopoietic stem cells: Comparison of endonucleases and homologous donor templates","volume":"27","author":"Romero","year":"2019","journal-title":"Mol Ther"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1242\/bio.013201","article-title":"Influence of age, irradiation and humanization on NSG mouse phenotypes","volume":"4","author":"Knibbe-Hollinger","year":"2015","journal-title":"Biol Open"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41434-020-0150-z","article-title":"\u2018Optimizing lentiviral vector transduction of hematopoietic stem cells for gene therapy\u2019","volume":"27","author":"Jang","year":"2020","journal-title":"Gene Ther"},{"key":"B31","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1182\/blood-2019-127439","article-title":"Enhanced transduction lentivector gene therapy for treatment of older patients with X-linked severe combined immunodeficiency","volume":"134","author":"De Ravin","year":"2019","journal-title":"Blood"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2019.05.015","article-title":"Enhancing lentiviral and alpharetroviral transduction of human hematopoietic stem cells for clinical application","volume":"14","author":"Schott","year":"2019","journal-title":"Mol Ther Methods Clin Dev"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.19.8705","article-title":"Tyrosine phosphorylation and activation of STAT5, STAT3, and janus kinases by interleukins 2 and 15","volume":"92","author":"Johnston","year":"1995","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-021-00989-6","article-title":"Gene editing rescues In vitro T cell development of RAG2-deficient induced pluripotent stem cells in an artificial thymic organoid system","volume":"41","author":"Gardner","year":"2021","journal-title":"J Clin Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-11-055442","article-title":"Limiting {gamma}c expression differentially affects signaling via the interleukin (IL)-7 and IL-15 receptors","volume":"110","author":"Smyth","year":"2007","journal-title":"Blood"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2027675","article-title":"Autologous ex vivo lentiviral gene therapy for adenosine deaminase deficiency","volume":"384","author":"Kohn","year":"2021","journal-title":"N Engl J Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.04.103","article-title":"Site-specific gene editing of human hematopoietic stem cells for X-linked hyper-IgM syndrome","volume":"23","author":"Kuo","year":"2018","journal-title":"Cell Rep"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2014.87","article-title":"Dual-regulated lentiviral vector for gene therapy of X-linked chronic granulomatosis","volume":"22","author":"Chiriaco","year":"2014","journal-title":"Mol Ther"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1089\/hgtb.2012.157","article-title":"\u2018Human miR223 promoter as a novel myelo-specific promoter for chronic granulomatous disease gene therapy","volume":"24","author":"Brendel","year":"2013","journal-title":"Hum Gene Ther Methods"},{"key":"B40","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.omtm.2020.04.006","article-title":"Creating new beta-Globin-Expressing lentiviral vectors by high-resolution mapping of locus control region enhancer sequences","volume":"17","author":"Morgan","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0551-y","article-title":"\u2018Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking\u2019","volume":"38","author":"Ferrari","year":"2020","journal-title":"Nat Biotechnol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"551-65 e8","DOI":"10.1016\/j.stem.2019.02.019","article-title":"Precise gene editing preserves hematopoietic stem cell function following transient p53-mediated DNA damage response","volume":"24","author":"Schiroli","year":"2019","journal-title":"Cell Stem Cell"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1067417\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T11:04:54Z","timestamp":1672830294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1067417\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,4]]},"references-count":42,"alternative-id":["10.3389\/fimmu.2022.1067417"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1067417","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,4]]},"article-number":"1067417"}}